Press Release
NPS Pharmaceuticals to Present at the JPMorgan 26th Annual Healthcare Conference on January 9, 2008
BEDMINSTER, N.J., Dec 21, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that Dr. Anthony Coles, president and CEO, will present a company update at the JPMorgan 26th Annual Healthcare Conference in San Francisco, CA at 8:30 a.m. PST on Wednesday, January 9, 2008. The live event webcast may be accessed on the NPS site, http://www.npsp.com. A replay will be available approximately 24 hours after the presentation has concluded and may be accessed at the same link.
About NPS Pharmaceuticals
NPS Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of small molecules and recombinant proteins as drugs, primarily for the treatment of metabolic, bone and mineral, and central nervous system disorders. The company has drug candidates in various stages of clinical development. Additional information is available on the company's website, http://www.npsp.com.
SOURCE NPS Pharmaceuticals, Inc.
http://www.npsp.com
The reports filed by NPS with the Securities and Exchange Commission and the news releases issued by NPS and posted on this website are current only as of the dates on which they were filed or issued by NPS. Therefore, the contents of these reports and releases can become outdated. We make no commitment, and disclaim any duty, to update these reports and releases. We do not warrant the accuracy or completeness of these materials or the reliability of any advice, opinion, statement or other information displayed or distributed through the website. Readers acknowledge that any reliance on these reports, releases, advice, opinions, statements, or information are at the reader’s sole risk.